Akanda Corp.

Equities

AKAN

CA00971M2058

Healthcare Facilities & Services

Market Closed - Nasdaq Other stock markets 21:00:00 17/05/2024 BST			5-day change	1st Jan Change
0.1726 ^USD	+30.26%		+88.63%	-60.82%

05-17	Top Midday Gainers	MT
05-17	Akanda Launches $2.5 Million Securities Offering; Shares Rise	MT

Akanda Corp. Reports Earnings Results for the Full Year Ended December 31, 2023

May 01, 2024 at 06:34 pm

Akanda Corp. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 2.16 million compared to USD 2.62 million a year ago.

Net loss was USD 32.28 million compared to USD 11.66 million a year ago. Basic loss per share from continuing operations was USD 7.16 compared to USD 2.75 a year ago. Diluted loss per share from continuing operations was USD 7.16 compared to USD 2.75 a year ago.

Basic loss per share was USD 7.16 compared to USD 3.86 a year ago. Diluted loss per share was USD 7.16 compared to USD 3.86 a year ago.

Latest news about Akanda Corp.

Top Midday Gainers	05-17	MT
Akanda Launches $2.5 Million Securities Offering; Shares Rise	05-17	MT
US Futures Nudge Higher Premarket Friday as Investors Await Leading Economic Indicators	05-17	MT
Top Premarket Gainers	05-17	MT
Akanda Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	05-01	CI
Akanda Corp. Announces Board Changes	04-26	CI
Akanda Corp. Announces Commercialize and Capitalize on Germany?s Legalization of Cannabis, Opening Path to $3 billion Market and Plans to Enter Blockchain and AI Technology Sector	04-12	CI
Akanda Corp. Announces Strategic Plan to Evaluate and Enter Bitcoin, Blockchain, AI Segments of Cannabis Market	03-28	CI
SOMAI Pharmaceuticals Inc. entered into Non-Binding Letter of Intent to acquire Rpk Biopharma, Unipessoal, Lda from Akanda Corp. for ?1.85 million.	02-01	CI
Akanda Corp. Reports Earnings Results for the Half Year Ended June 30, 2023	12-29	CI
Akanda Hires Charn Deol as CFO	12-12	MT
Akanda Corp. Appoints Charn Deol as Chief Financial Officer	12-12	CI
Akanda Gets Nasdaq Notice on Minimum Bid Price Deficiency	06/07/23	MT
Akanda Corp. Announces Termination of Loan Agreement	30/05/23	CI
Akanda Terminates Loan Agreement With Veridia Canada	30/05/23	MT
Akanda Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	02/05/23	CI
Akanda Corp. Auditor Raises 'Going Concern' Doubt	01/05/23	CI
Akanda Corp. Announces That It Has Entered into A Loan Agreement with Veridia Canada Ltd	01/05/23	CI
Akanda Regains Compliance With Nasdaq Listing Requirements	29/03/23	MT
Certain Common Shares of Akanda Corp. are subject to a Lock-Up Agreement Ending on 14-MAR-2023.	13/03/23	CI
Akanda Plans 1-for-10 Reverse Stock Split; Shares Fall	08/03/23	MT
North American Morning Briefing : Stock Futures -2-	08/03/23	DJ
Akanda Names Shailesh Bhushan Finance Chief	08/03/23	MT
Akanda Corporation Announces Appointment of Shailesh Bhushan as Chief Financial Officer	07/03/23	CI
Akanda Corp. Announces Board Changes	16/02/23	CI

Chart Akanda Corp.

Duration

Period

More charts

Company Profile

Akanda Corp. is an international medical cannabis and wellness platform company. The Companyâs portfolio includes Canmart Ltd. (CanMart), a United Kingdom-based fully licensed pharmaceutical importer and distributor which supplies pharmacies and clinics within the United Kingdom. Canmart is a licensed importer and distributor of CBD Extraction for Medicinal Purposes (CBPMs) in the United Kingdom. CanMart holds a controlled drug license issued by the Home Office to possess and supply CBPMs in the United Kingdom. The Company's seed-to-patient supply chain also includes partnerships Cellen Life Sciences' Leva Clinic, a fully digital pain clinic in the United Kingdom. The Company also develops a Canadian farming property in British Columbia, including farming land and related operations and licenses. The Company also focuses on developing tetrahydrocannabinol (THC) and cannabinoid (CBD) facilities at this site.

Sector

Healthcare Facilities & Services

More about the company

Income Statement Evolution

More financial data

Sector Medical Farming

	1st Jan change	Capi.
AKANDA CORP.	-60.82%	1.12M
CRUCIAL INNOVATIONS CORP.	-.--%	339M
THE CANNABIST COMPANY HOLDINGS INC.	-37.75%	335M
AYR WELLNESS INC.	+52.26%	316M
ASCEND WELLNESS HOLDINGS, INC.	+35.05%	291M
ORGANIGRAM HOLDINGS INC.	+57.56%	210M
JUSHI HOLDINGS INC.	+52.17%	142M
INTERCURE LTD.	+140.77%	137M
4FRONT VENTURES CORP.	+34.62%	128M
IANTHUS CAPITAL HOLDINGS, INC.	-28.57%	121M

Medical Farming